Supporting Clinical Research at the Bedside

Article

In this video Pamela K. Ginex, EdD, RN, OCN, discusses a successful partnership between a clinical librarian and the nursing staff at her institution, a collaboration that benefits staff and, ultimately, patients.

In this video Pamela K. Ginex, EdD, RN, OCN, a nurse scientist at the Memorial Sloan Kettering Cancer Center in New York, discusses a successful partnership between a clinical librarian and the nursing staff at her institution, a collaboration that benefits staff and, ultimately, patients.

Please note: Due to technical difficulties with the audio during the shooting of this video, we’ve provided a transcript of the discussion below.

My name is Pamela Ginex, I’m a nurse scientist at Memorial Sloan Kettering, and this is a poster about a collaboration our nursing department has with our medical librarian at Memorial Sloan Kettering.

We have a wonderful partnership where our medical librarian has dedicated time to work with the department of nursing-she comes to our research meetings, our practice meetings, and some of our other meetings to collaborate with nursing. So the nurses know her, love her, and she knows what questions we’re asking, what issues come up, and we’re also able to reach out to her for specific projects.

If we have an idea for an evidence-based practice project, performance improvement or a research project, our nurses are able to reach out to her and work collaboratively to evaluate the literature and see whether there are any gaps that we can fill, or what we’re able to work on going forward.

It’s a great resource for us, because we have a beautiful medical library, lots of librarians who are great resources, so it’s really nice to have dedicated time for a librarian for nursing. We see the benefit of having that collaboration. She’s integrated with all our department and nurses can reach out to her. She does thousands of literature searches a year for the department of nursing, and it’s a huge resource for us. We wanted to highlight that in our poster because we think this may be a resource that other hospitals have that they may be able to capitalize on.

Clinical nurses are very busy-they’re at the bedside, they’re at the chair side, they’re the ones that have the questions and are able to ask the most relevant questions, but they need resources to then answer those questions. This is sort of the first stop in that journey where they’ve evaluated literature to see what is known and what is not known and where the gaps are. We wanted to highlight that here as we feel this is a great resource for our nurses and hopefully other nurses will be able to take advantage of their medical librarians as well.

 

Related Videos
Barbara Smith, MD, PhD, spoke about the potential use of pegulicianine-guided breast cancer surgery based on reports from the phase 3 INSITE trial.
Patient-reported symptoms following surgery appear to improve with the use of perioperative telemonitoring, says Kelly M. Mahuron, MD.
Treatment options in the refractory setting must improve for patients with resected colorectal cancer peritoneal metastasis, says Muhammad Talha Waheed, MD.
Although immature, overall survival data from the KEYNOTE-868 trial may support the use of pembrolizumab plus chemotherapy in patients with endometrial cancer.
Dostarlimab plus chemotherapy appears to yield favorable overall survival in patients with mismatch repair proficient endometrial cancer.
Some patients with large B-cell lymphoma may have to travel a great distance for an initial evaluation for CAR T-cell therapy.
Brian Slomovitz, MD, MS, FACOG discusses the use of new antibody drug conjugates for treating patients with various gynecologic cancers.
Education is essential to referring oncologists manage toxicities associated with CAR T-cell therapy for patients with large B-cell lymphoma.
There is no absolute age cutoff where CAR T cells are contraindicated for those with large B-cell lymphoma, says David L. Porter, MD.
David L. Porter, MD, emphasizes referring patients with large B-cell lymphoma early for CAR T-cell therapy consultation.
Related Content